TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

QIACUBE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

QIACUBE

ST13

US500000079037735

Classe

1, 5, 9, 42

Pedido

79037735

Registro

3445464

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

45

Atualização mais recente

13/02/2019

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 42

Data de depósito

28/08/2006

Data de registro

10/06/2008

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

06/06/2018

Última transação

06/06/2018

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

40724 Hilden, DE

Examinador

SETTLES LEWIS, SHAILA E

Unidade examinadora

M50

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

QIAGEN GmbH

Representantes

Victoria Friedman Dennemeyer & Associates, LLC

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, [ polymerases, reagents for staining and marking, ] molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; Materials for columns and reagents and solvents for sample preparation, all of the foregoing for the purpose of purification, lysis, [ modification and manipulation of cells, ] as well as for the performance of [ marking, ] separation, isolation, purification, [ amplification and analytical methods for biopolymers, ] in particular nucleic acids, enzymes, [ proteins, macro molecules and biologically active substances ] for separation, [ analysis ] and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; Kits comprising chemical, biochemical and biotechnological products for sample preparation, purification, lysis, [ modification and manipulation of cells ] as well as for the performance of [ marking, ] separation, isolation, purification, [ amplification and analytical methods for biopolymers, ] in particular nucleic acids, enzymes, [ proteins, macro molecules and biologically active substances ] for separation, [ analysis ] and purification of biological and biochemical compounds, in particular nucleic acids made from biological and biochemical sample material, none of the foregoing for medical or veterinary purposes

Classe 5

[ Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer chemicals and aqueous and non-aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and materials for columns for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; Products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products as well as kits comprising products for medical and veterinary medical purposes, in particular chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, genetic information and conditions of the human body ]

Classe 9

Scientific apparatus, instruments and equipment for research and examination purposes, namely, laboratory equipment, [ namely, chromatography columns; ] automated laboratory equipment, namely, robots and spare parts and add-ons [ therefor, namely, preprogrammed smart cards for DNA purification protocols; ] laboratory equipment, namely, microplates; laboratory equipment, namely, pipettes, pipette tips and pipette tip holders; laboratory equipment, namely, sample containers, reagent holders, flasks, reagent tube holders, holders for micro containers, [ magnetic syringes, biochips for the purpose of screen large numbers of biological analytes, thermocyclers for the purpose of performing polymerase chain reactions, ] homogenizers for the purpose of breaking up cell membranes and mixing the resulting liquids, and vacuum valves for the purpose of permitting the operation of laboratory processes under subatmospheric pressure, all of the aforementioned being included in this class and being for scientific research and examination purposes

Classe 42

[ Scientific research for others in the fields of chemistry, genetics, biology and biochemistry; Scientific diagnostic services for others in the fields of DNA, RNA and protein detection and analysis; Research services in the field of forensic science, namely, analysis, detection and isolation of biological substances in forensic samples ]

Publicações

Histórico de despachos e eventos da marca no USPTO.

45 publicações encontradas

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

13/02/2019

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

06/02/2019

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/06/2018

71AG

REGISTERED-SEC.71 ACCEPTED

06/06/2018

ES71

TEAS SECTION 71 RECEIVED

31/05/2018

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

10/06/2017

RNWL

INTERNATIONAL REGISTRATION RENEWED

15/09/2016

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

31/07/2015

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

10/07/2015

INPC

INVALIDATION PROCESSED

10/07/2015

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

08/03/2015

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

08/07/2014

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

08/07/2014

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

24/06/2014

ES75

TEAS SECTION 71 & 15 RECEIVED

04/06/2014

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

30/12/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

14/01/2009

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

14/01/2009

FICS

FINAL DISPOSITION NOTICE SENT TO IB

29/09/2008

FIMP

FINAL DISPOSITION PROCESSED

29/09/2008

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/09/2008

R.PR

REGISTERED-PRINCIPAL REGISTER

10/06/2008

PUBO

PUBLISHED FOR OPPOSITION

25/03/2008

NPUB

NOTICE OF PUBLICATION

05/03/2008

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

20/02/2008

ALIE

ASSIGNED TO LIE

20/02/2008

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

18/01/2008

XAEC

EXAMINER'S AMENDMENT ENTERED

14/01/2008

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

14/01/2008

GNEA

EXAMINERS AMENDMENT E-MAILED

14/01/2008

CNEA

EXAMINERS AMENDMENT -WRITTEN

14/01/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

21/12/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/12/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

21/12/2007

FAXX

FAX RECEIVED

17/12/2007

RFNT

REFUSAL PROCESSED BY IB

20/07/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

18/07/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

18/07/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

28/06/2007

RFRR

REFUSAL PROCESSED BY MPU

28/06/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

28/06/2007

CNRT

NON-FINAL ACTION WRITTEN

27/06/2007

DOCK

ASSIGNED TO EXAMINER

08/06/2007

NWAP

NEW APPLICATION ENTERED

08/06/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/06/2007

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace QIACUBE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.